Andrew M. Radin

Andrew M. Radin

Gründer bei Aria Pharmaceuticals, Inc.

Retail Trade

Ursprung des Netzwerks ersten Grades von Andrew M. Radin

EinheitArt der EinheitIndustrie
7
Holding Company Drugstore Chains 7

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Andrew M. Radin

UnternehmenSektorVerknüpfte PersonenHauptposition
Massachusetts Institute of Technology College/University

Howard Rosen

Vijay Pande

Graduate Degree

Doctorate Degree

Investment Managers

Jorge Conde

Vijay Pande

Private Equity Investor

Private Equity Investor

Stanford University College/University

Howard Rosen

Vijay Pande

Undergraduate Degree

Corporate Officer/Principal

Packaged Software

Jorge Conde

Director/Board Member

Evixar

Jun-Pyo Lee

Chief Executive Officer

Commercial Printing/Forms

Jun-Pyo Lee

Corporate Officer/Principal

Electronics Distributors

Jun-Pyo Lee

Corporate Officer/Principal

Packaged Software

Jun-Pyo Lee

Corporate Officer/Principal

Miscellaneous Commercial Services

Jorge Conde

Director/Board Member

Packaged Software

Jorge Conde

Director/Board Member

Investment Managers

Jun-Pyo Lee

Chief Executive Officer

Biotechnology

Jorge Conde

Director/Board Member

EQRX, INC. Pharmaceuticals: Major

Jorge Conde

Director/Board Member

Miscellaneous Commercial Services

Jorge Conde

Director/Board Member

Miscellaneous Commercial Services

Jorge Conde

Director/Board Member

Pharmaceuticals: Major

Jorge Conde

Director/Board Member

Korea Advanced Institute of Science & Technology College/University

Jun-Pyo Lee

Undergraduate Degree

Biotechnology

Vijay Pande

Director/Board Member

Princeton University College/University

Vijay Pande

Undergraduate Degree

Harvard Business School College/University

Jorge Conde

Masters Business Admin

Packaged Software

Vijay Pande

Director/Board Member

Computer Peripherals

Vijay Pande

Director/Board Member

Biotechnology

Vijay Pande

Director/Board Member

Packaged Software

Vijay Pande

Director/Board Member

Information Technology Services

Vijay Pande

Director/Board Member

NAUTILUS BIOTECHNOLOGY, INC. Biotechnology

Vijay Pande

Director/Board Member

Internet Software/Services

Vijay Pande

Director/Board Member

PDL BIOPHARMA, INC. Biotechnology

Jill Jene

Corporate Officer/Principal

College/University

Jill Jene

Doctorate Degree

DePaul University College/University

Jill Jene

Masters Business Admin

Bradley University College/University

Jill Jene

Undergraduate Degree

ADAMAS PHARMACEUTICALS, INC. Pharmaceuticals: Major

Jill Jene

Corporate Officer/Principal

Harvard Mit Health Sciences & Technology College/University

Jorge Conde

Graduate Degree

MORGAN STANLEY Investment Managers

Jorge Conde

Corporate Officer/Principal

SYROS PHARMACEUTICALS, INC. Biotechnology

Jorge Conde

Director of Finance/CFO

Stanford Graduate School of Business College/University

Howard Rosen

Masters Business Admin

ALZA CORPORATION Pharmaceuticals: Major

Howard Rosen

President

Information Technology Services

Howard Rosen

Corporate Officer/Principal

Biotechnology

Howard Rosen

Corporate Officer/Principal

GILEAD SCIENCES, INC. Biotechnology

Howard Rosen

Corporate Officer/Principal

TALPHERA, INC. Pharmaceuticals: Major

Howard Rosen

Chief Executive Officer

Pharmaceuticals: Major

Howard Rosen

Director/Board Member

Miscellaneous Commercial Services

Howard Rosen

Corporate Officer/Principal

Miscellaneous Commercial Services

Howard Rosen

Corporate Officer/Principal

NTF Therapeutics, Inc.

Howard Rosen

Director/Board Member

Pharmaceuticals: Major

Howard Rosen

Director/Board Member

Statistik

International

Vereinigte Staaten 44
Südkorea 6
Japan 2
Israel 2

Sektoral

Health Technology 19
Consumer Services 10
Technology Services 10
Commercial Services 7
Finance 5

Operativ

Director/Board Member 37
Corporate Officer/Principal 17
Independent Dir/Board Member 6
Chief Executive Officer 5
Undergraduate Degree 5
  1. Börse
  2. Insiders
  3. Andrew M. Radin
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT